TCGX Acquisition TCGX
TCGX Acquisition Acquires TriGemX Bio
Item 1.01 Enters material agreement
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001193125-26-424754
- Business Combination expected to close in Q1 2027
- TCGX Acquisition to rebrand as TriGemX Bio, Inc.
- Exchange ratio based on $361M pre-money valuation
- Shareholders can redeem Class A shares for trust funds
Written from the 8-K on EDGAR. Check the filing before you rely on it.
Similar companies
Same SIC code (6770) and public float not reported.